3-37025608-A-ATTTT
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000249.4(MLH1):c.1039-11_1039-8dupTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00052   (  0   hom.,  cov: 0) 
 Exomes 𝑓:  0.0011   (  7   hom.  ) 
Consequence
 MLH1
NM_000249.4 splice_region, intron
NM_000249.4 splice_region, intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  -0.0340  
Publications
1 publications found 
Genes affected
 MLH1  (HGNC:7127):  (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017] 
MLH1 Gene-Disease associations (from GenCC):
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
 - Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
 - Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
 - mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
 - Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
 - prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 - breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
 - hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 3-37025608-A-ATTTT is Benign according to our data. Variant chr3-37025608-A-ATTTT is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 433862.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000518 (25/48266) while in subpopulation EAS AF = 0.00291 (6/2060). AF 95% confidence interval is 0.00127. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check. 
BS2
High Homozygotes in GnomAdExome4 at 7 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.000518  AC: 25AN: 48278Hom.:  0  Cov.: 0 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
25
AN: 
48278
Hom.: 
Cov.: 
0
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00201  AC: 28AN: 13956 AF XY:  0.00155   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
28
AN: 
13956
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00108  AC: 278AN: 258116Hom.:  7  Cov.: 0 AF XY:  0.00110  AC XY: 141AN XY: 128114 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 exome 
 AF: 
AC: 
278
AN: 
258116
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
141
AN XY: 
128114
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
7
AN: 
3328
American (AMR) 
 AF: 
AC: 
4
AN: 
1274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
5
AN: 
2086
East Asian (EAS) 
 AF: 
AC: 
10
AN: 
3036
South Asian (SAS) 
 AF: 
AC: 
21
AN: 
5282
European-Finnish (FIN) 
 AF: 
AC: 
3
AN: 
1222
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
524
European-Non Finnish (NFE) 
 AF: 
AC: 
212
AN: 
232642
Other (OTH) 
 AF: 
AC: 
15
AN: 
8722
 ⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.346 
Heterozygous variant carriers
 0 
 20 
 41 
 61 
 82 
 102 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.000518  AC: 25AN: 48266Hom.:  0  Cov.: 0 AF XY:  0.000512  AC XY: 11AN XY: 21484 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
25
AN: 
48266
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
11
AN XY: 
21484
show subpopulations 
African (AFR) 
 AF: 
AC: 
4
AN: 
12042
American (AMR) 
 AF: 
AC: 
3
AN: 
3256
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
1520
East Asian (EAS) 
 AF: 
AC: 
6
AN: 
2060
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
1336
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
876
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
44
European-Non Finnish (NFE) 
 AF: 
AC: 
10
AN: 
26184
Other (OTH) 
 AF: 
AC: 
0
AN: 
606
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.445 
Heterozygous variant carriers
 0 
 1 
 3 
 4 
 6 
 7 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:2 
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 13, 2013
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
MLH1: BP4, BS2 -
Hereditary nonpolyposis colorectal neoplasms    Benign:1 
Feb 05, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
 La Branchor 
 BranchPoint Hunter 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.